Limbaga, Bb Boy .

HRN: 27-35-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFTRIAXONE 1G (VIAL)
06/24/2025
07/01/2025
IV
500mg
Q12
Typhoid Fever
Waiting Final Action 
06/26/2025
MUPIROCIN 2%, 15G (TUBE)
06/26/2025
07/02/2025
TOPICAL
Thin Layer
TID
IV Site Infection
Waiting Final Action 
06/26/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
06/26/2025
07/02/2025
TOPICAL
Thin Layer
TID
IV Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: